115 related articles for article (PubMed ID: 33608720)
21. Claudin-7 and claudin-8: immunohistochemical markers for the differential diagnosis of chromophobe renal cell carcinoma and renal oncocytoma.
Osunkoya AO; Cohen C; Lawson D; Picken MM; Amin MB; Young AN
Hum Pathol; 2009 Feb; 40(2):206-10. PubMed ID: 18799195
[TBL] [Abstract][Full Text] [Related]
22. Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications.
Kuehn A; Paner GP; Skinnider BF; Cohen C; Datta MW; Young AN; Srigley JR; Amin MB
Am J Surg Pathol; 2007 Oct; 31(10):1528-33. PubMed ID: 17895753
[TBL] [Abstract][Full Text] [Related]
23. Diagnosing primary and metastatic renal cell carcinoma: the use of the monoclonal antibody 'Renal Cell Carcinoma Marker'.
McGregor DK; Khurana KK; Cao C; Tsao CC; Ayala G; Krishnan B; Ro JY; Lechago J; Truong LD
Am J Surg Pathol; 2001 Dec; 25(12):1485-92. PubMed ID: 11717537
[TBL] [Abstract][Full Text] [Related]
24. Expression of S100A4 in renal epithelial neoplasms.
Wang LJ; Matoso A; Sciandra KT; Yakirevich E; Sabo E; Zhang Y; Meitner PA; Tavares R; Noble L; Pareek G; DeLellis RA; Resnick MB
Appl Immunohistochem Mol Morphol; 2012 Jan; 20(1):71-6. PubMed ID: 21691200
[TBL] [Abstract][Full Text] [Related]
25. Chromophobe renal cell carcinoma with neuroendocrine and neuroendocrine-like features. Morphologic, immunohistochemical, ultrastructural, and array comparative genomic hybridization analysis of 18 cases and review of the literature.
Peckova K; Martinek P; Ohe C; Kuroda N; Bulimbasic S; Condom Mundo E; Perez Montiel D; Lopez JI; Daum O; Rotterova P; Kokoskova B; Dubova M; Pivovarcikova K; Bauleth K; Grossmann P; Hora M; Kalusova K; Davidson W; Slouka D; Miroslav S; Buzrla P; Hynek M; Michal M; Hes O
Ann Diagn Pathol; 2015 Aug; 19(4):261-8. PubMed ID: 26031603
[TBL] [Abstract][Full Text] [Related]
26. RNAscope CSF1 chromogenic in situ hybridization: a potentially useful tool in the differential diagnosis of tenosynovial giant cell tumors.
Thangaiah JJ; Koepplin JW; Folpe AL
Hum Pathol; 2021 Sep; 115():1-9. PubMed ID: 34058245
[TBL] [Abstract][Full Text] [Related]
27. Fluorescent In-situ Hybridization Study of Non-papillary Oncocytic/Eosinophilic Renal Cell Carcinoma.
Mai KT; Ahmed I; Levac J; Nguyen BN
Appl Immunohistochem Mol Morphol; 2011 Jan; 19(1):82-91. PubMed ID: 20861792
[TBL] [Abstract][Full Text] [Related]
28. Analysis of clinicopathologic predictors of oncologic outcome provides insight into the natural history of surgically managed papillary renal cell carcinoma.
Margulis V; Tamboli P; Matin SF; Swanson DA; Wood CG
Cancer; 2008 Apr; 112(7):1480-8. PubMed ID: 18240184
[TBL] [Abstract][Full Text] [Related]
29. Oncocytoma can be differentiated from its renal cell carcinoma mimics by a panel of markers: an automated tissue microarray study.
Huang W; Kanehira K; Drew S; Pier T
Appl Immunohistochem Mol Morphol; 2009 Jan; 17(1):12-7. PubMed ID: 18769342
[TBL] [Abstract][Full Text] [Related]
30. VHL and FHIT locus loss of heterozygosity is common in all renal cancer morphotypes but differs in pattern and prognostic significance.
Velickovic M; Delahunt B; Störkel S; Grebem SK
Cancer Res; 2001 Jun; 61(12):4815-9. PubMed ID: 11406557
[TBL] [Abstract][Full Text] [Related]
31. Different vascular endothelial growth factor (VEGF), VEGF-receptor 1 and -2 mRNA expression profiles between clear cell and papillary renal cell carcinoma.
Ljungberg BJ; Jacobsen J; Rudolfsson SH; Lindh G; Grankvist K; Rasmuson T
BJU Int; 2006 Sep; 98(3):661-7. PubMed ID: 16925769
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical analysis of chromophobe renal cell carcinoma, renal oncocytoma, and clear cell carcinoma: an optimal and practical panel for differential diagnosis.
Liu L; Qian J; Singh H; Meiers I; Zhou X; Bostwick DG
Arch Pathol Lab Med; 2007 Aug; 131(8):1290-7. PubMed ID: 17683191
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic implications of transcription factor Pax 2 protein and transmembrane enzyme complex carbonic anhydrase IX immunoreactivity in adult renal epithelial neoplasms.
Gupta R; Balzer B; Picken M; Osunkoya AO; Shet T; Alsabeh R; Luthringer D; Paner GP; Amin MB
Am J Surg Pathol; 2009 Feb; 33(2):241-7. PubMed ID: 18941400
[TBL] [Abstract][Full Text] [Related]
34. [Diagnostic utility of S100A1, GLUT-1 and Caveolin-1 in renal tumors with oncocytic features: a comparative study].
Zhang W; Wang K; Yu W; Liu Y; Chu J; Jiang Y; Li Y
Zhonghua Bing Li Xue Za Zhi; 2015 Nov; 44(11):767-71. PubMed ID: 26888385
[TBL] [Abstract][Full Text] [Related]
35. A collision tumor of papillary renal cell carcinoma and oncocytoma: case report and literature review.
Goyal R; Parwani AV; Gellert L; Hameed O; Giannico GA
Am J Clin Pathol; 2015 Nov; 144(5):811-6. PubMed ID: 26486747
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic and prognostic role of immunohistochemical expression of napsin-A aspartic peptidase in clear cell and papillary renal cell carcinoma: a study including 233 primary and metastatic cases.
Xu B; Abourbih S; Sircar K; Kassouf W; Aprikian A; Tanguay S; Brimo F
Appl Immunohistochem Mol Morphol; 2014 Mar; 22(3):206-12. PubMed ID: 23702650
[TBL] [Abstract][Full Text] [Related]
37. Expression of alpha-methylacyl-CoA racemase in papillary renal cell carcinoma.
Tretiakova MS; Sahoo S; Takahashi M; Turkyilmaz M; Vogelzang NJ; Lin F; Krausz T; Teh BT; Yang XJ
Am J Surg Pathol; 2004 Jan; 28(1):69-76. PubMed ID: 14707866
[TBL] [Abstract][Full Text] [Related]
38. Tissue and urinary KIM-1 relate to tumor characteristics in patients with clear renal cell carcinoma.
Mijuskovic M; Stanojevic I; Milovic N; Cerovic S; Petrovic D; Maksic D; Kovacevic B; Andjelic T; Aleksic P; Terzic B; Djukic M; Vojvodic D
Int Urol Nephrol; 2018 Jan; 50(1):63-70. PubMed ID: 29052086
[TBL] [Abstract][Full Text] [Related]
39. Utility of CD10 and RCCma in the diagnosis of metastatic conventional renal-cell adenocarcinoma by fine-needle aspiration biopsy.
Simsir A; Chhieng D; Wei XJ; Yee H; Waisman J; Cangiarella J
Diagn Cytopathol; 2005 Jul; 33(1):3-7. PubMed ID: 15945081
[TBL] [Abstract][Full Text] [Related]
40. C-kit expression in renal oncocytomas and chromophobe renal cell carcinomas.
Huo L; Sugimura J; Tretiakova MS; Patton KT; Gupta R; Popov B; Laskin WB; Yeldandi A; Teh BT; Yang XJ
Hum Pathol; 2005 Mar; 36(3):262-8. PubMed ID: 15791570
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]